Search results
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
The Woonsocket Call· 4 days agoSyndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that on June 1, 2024 the Company granted ...
Arrivent Biopharma enters into cancer drug development collaboration valued at up to $615M -...
The Business Journals· 2 days agoAntibody drug conjugates, or ADCs, are a type of cancer treatment that combines a monoclonal ...
Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of...
Morningstar· 5 days agoGilead and Arcus Announce EtrumadenantPlus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer – In Cohort B of the ARC-9 mCRC Study, Etrumadenant ...
Celularity reports advances in cancer T-cell therapy By Investing.com
Investing.com· 4 days agoCelularity Inc. (NASDAQ: CELU), a biotechnology firm specializing in regenerative medicine,...
S2 Episode 3: How Do You Treat Refractory Colorectal Cancer?
Medscape· 3 days agoFor more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify,...
Limited-Stage SCLC Gets a New Standard of Care With Consolidation Durvalumab
MedPage Today· 5 days agoConsolidation treatment with durvalumab (Imfinzi) following concurrent chemoradiotherapy...
Adding Isatuximab to Standard Backbone Improves Outcomes in Multiple Myeloma
MedPage Today· 4 days agoTwo trials show positive outcomes
Balanced Sourcing Of Custom Media/Buffer Formulations, Part 2: The Case For Insourcing
BioresearchOnline· 1 day agoIn Part 2, we are flipping the proverbial coin to discuss key considerations in the case for...
Qilu Pharmaceutical's Three Clinical Studies on Cancer Immunotherapy Presented at ASCO 2024
FOX 16 Little Rock· 10 hours agoThe 2024 American Society of Clinical Oncology (ASCO) Annual Meeting convened from May 31 to June 4, 2024 in Chicago, USA, adopting a hybrid format. Among the presented works, three clinical ...
Stocks making the biggest moves midday: Five Below, Salesforce, Lululemon, Instacart and more
CNBC· 1 day agoCheck out the companies making headlines in midday trading: Five Below — Shares of Five Below sank...